Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.5 USD | -2.65% | -5.09% | +3.91% |
04-01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
04-01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.91% | 955M | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+16.08% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- Transcript : Liquidia Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 11